LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: Biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects

Mechanisms of Ageing and Development

Volumn 132, Issue 3, 2011, Pages 86-92

  Balistreri, Carmela Rita ^a   Caruso, Calogero ^a   Listì, Florinda ^a   Colonna Romano, Giuseppina ^a   Lio, Domenico ^a   Candore, Giuseppina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Ageing; Cytokines; Eicosanoids; Genetics; Inflammation; Longevity; TLR4

Indexed keywords

ADENINE; ARACHIDONATE 5 LIPOXYGENASE; CYTOKINE; CYTOSINE; GENE PRODUCT; GUANINE; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 6; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; PROTEIN PTGS2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE MUTATION; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; ITALY; MALE; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CYTOKINES; DINOPROSTONE; FEMALE; HUMANS; ITALY; LEUKOTRIENE B4; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4;

EID: 79952758944     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2010.12.005     Document Type: Article

References (57)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
2. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., Lowry S.F. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 2002, 186:1522-1525.
3. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
4. Balistreri C.R., Candore G., Colonna-Romano G., Lio D., Caruso M., Hoffmann E., Franceschi C., Caruso C. Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 2004, 292:2339-2340.
5. Balistreri C.R., Candore G., Lio D., Colonna-Romano G., Di Lorenzo G., Mansueto P., Rini G., Mansueto S., Cillari E., Franceschi C., Caruso C. Role of TLR4 receptor polymorphisms in Boutonneuse fever. Int. J. Immunopathol. Pharmacol. 2005, 18:655-660.
6. Balistreri C.R., Grimaldi M.P., Chiappelli M., Licastro F., Castiglia L., Listì F., Vasto S., Lio D., Caruso C., Candore G. Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease. Curr. Pharm. Des. 2008, 14:2672-2677.
7. Balistreri C.R., Colonna-Romano G., Lio D., Candore G., Caruso C. TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J. Clin. Immunol. 2009, 29:406-415.
8. Balistreri C.R., Caruso C., Carruba G., Miceli V., Campisi I., Lio D., Colonna-Romano G., Listì F., Candore G. Prostate cancer risk and pro-inflammatory polymorphisms: their pathophysiology and therapeutic implications in a pilot study. Curr. Pharm. Des. 2010, 16:718-724.
9. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr. Top. Microbiol. Immunol. 2002, 270:109-120.
10. Bostock C.V., Soiza R.L., Whalley L.J. Genetic determinants of ageing processes and diseases in later life. Maturitas 2009, 62:225-229.
11. Boyce J.A. Eicosanoids in asthma, allergic inflammation, and host defense. Curr. Mol. Med. 2008, 8:335-349.
12. Bruunsgaard H., Pedersen M., Pedersen B.K. 2001 aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001, 8:131-136.
13. Bucova M., Bernadic M., Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl. Lek. Listy 2008, 109:333-340.
14. Candore G., Balistreri C.R., Caruso M., Grimaldi M.P., Incalcaterra E., Listì F., Vasto S., Caruso C. Pharmacogenomics: a tool to prevent and cure coronary heart disease. Curr. Pharm. Des. 2007, 13:3726-3734.
15. Candore G., Balistreri C.R., Grimaldi M.P., Listì F., Vasto S., Chiappelli M., Licastro F., Colonna-Romano G., Lio D., Caruso C. Polymorphisms of pro-inflammatory genes and Alzheimer's disease risk: a pharmacogenomic approach. Mech. Ageing Dev. 2007, 128:67-75.
16. Caruso C., Candore G., Colonna-Romano G., Lio D., Franceschi C. Inflammation and life-span. Science 2005, 307:208-209.
17. Caruso C., Balistreri C.R., Candore G., Carruba G., Colonna-Romano G., Di Bona D., Forte G.I., Lio D., Listì F., Scola L., Vasto S. Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach. Cancer Immunol. Immunother. 2009, 58:1919-1933.
18. Child N.J., Yang I.A., Pulletz M.C., de Courcy-Golder K., Andrews A.L., Pappachan V.J., Holloway J.W. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem. Soc. Trans. 2003, 31(Pt 3):652-653.
19. Cipollone F., Toniato E., Martinotti S., Fazia M., Iezzi A., Cuccurullo C., Pini B., Ursi S., Vitullo G., Averna M., Arca M., Montali A., Campagna F., Ucchino S., Spigonardo F., Taddei S., Virdis A., Ciabattoni G., Notarbartolo A., Cuccurullo F., Mezzetti A. Identification of New Elements of Plaque Stability (INES) Study Group. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 2004, 291:2221-2228.
20. Davila S., Hibberd M.L. Genome-wide association studies are coming for human infectious diseases. Genome Med. 2009, 1:19.
21. Erridge C., Stewart J., Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J. Exp. Med. 2003, 197:1787-1791.
22. Ferwerda B., McCall M.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., Syafruddin D., Kibiki G., Cristea T., Hijmans A., Hamann L., Israel S., ElGhazali G., Troye-Blomberg M., Kumpf O., Maiga B., Dolo A., Doumbo O., Hermsen C.C., Stalenhoef A.F., van Crevel R., Brunner H.G., Oh D.Y., Schumann R.R., de la Rúa C., Sauerwein R., Kullberg B.J., van der Ven A.J., van der Meer J.W., Netea M.G. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16645-16650.
23. Ferwerda B., McCall M.B., Verheijen K., Kullberg B.J., van der Ven A.J., Van der Meer J.W., Netea M.G. Functional consequences of toll-like receptor 4 polymorphisms. Mol. Med. 2008, 14:346-352.
24. Goldstein D.B. Common genetic variation and human traits. N. Engl. J. Med. 2009, 360:1696-1698.
25. Grimble R.F. Inflammatory response in the elderly. Curr. Opin. Clin. Nutr. Metab. Care 2003, 6:21-29.
26. Heesen M., Bloemeke B., Kunz D. The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes. Eur. Cytokine Netw. 2003, 14:234-237.
27. Hirschhorn J.N. Genomewide association studies-illuminating biologic pathways. N. Engl. J. Med. 2009, 360:1699-1701.
28. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
29. Jirillo E., Candore G., Magrone T., Caruso C. A scientific approach to anti-ageing therapies: state of the art. Curr. Pharm. Des. 2008, 14:2637-2642.
30. Krabbe K.S., Pedersen M., Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 2004, 39:687-699.
31. Kraft P., Hunter D.J. Genetic risk prediction-are we there yet?. N. Engl. J. Med. 2009, 360:1701-1703.
32. Imahara S.D., Jelacic S., Junker C.E., O'Keefe G.E. The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes. Genes Immun. 2005, 6:37-43.
33. In K.H., Asano K., Beier D., Grobholz J., Finn P.W., Silverman E.K., Silverman E.S., Collins T., Fischer A.R., Keith T.P., Serino K., Kim S.W., De Sanctis G.T., Yandava C., Pillari A., Rubin P., Kemp J., Israel E., Busse W., Ledford D., Murray J.J., Segal A., Tinkleman D., Drazen J.M. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J. Clin. Invest. 1997, 99:1130-1137.
34. Leon L.R. Heat stroke and cytokines. Prog. Brain Res. 2007, 162:481-524.
35. Licastro F., Candore G., Lio D., Porcellini E., Colonna-Romano G., Franceschi C., Caruso C. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun. Ageing 2005, 2:8.
36. Lin B.K., Clyne M., Walsh M., Gomez O., Yu W., Gwinn M., Khoury M.J. Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am. J. Epidemiol. 2006, 164:1-4.
37. Lio D., Caruso C. IL-10, genetic polymorphism and its relevance to age-related diseases. Interleukin-10 2006, 93-106. Eureka.com, Georgetown, TX, USA. F.M. Marincola (Ed.).
38. Listì F., Caruso M., Incalcaterra E., Hoffmann E., Caimi G., Balistreri C.R., Vasto S., Scafidi V., Caruso C., Candore G. Pro-inflammatory gene variants in myocardial infarction and longevity: implications for pharmacogenomics. Curr. Pharm. Des. 2008, 14:2678-2685.
39. Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 2002, 162:1028-1032.
40. Michel O., LeVan T.D., Stern D., Dentener M., Thorn J., Gnat D., Beijer M.L., Cochaux P., Holt P.G., Martinez F.D., Rylander R. Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J. Allergy Clin. Immunol. 2003, 112:923-929.
41. Norata G.D., Garlaschelli K., Ongari M., Raselli S., Grigore L., Benvenuto F., Maggi F.M., Catapano A.L. Effect of the Toll-like receptor 4 (TLR-4) variants on intima media thickness and monocyte-derived macrophage response to LPS. J. Intern. Med. 2005, 258:21-27.
42. Orbe J., Beloqui O., Rodriguez J.A., Belzunce M.S., Roncal C., Páramo J.A. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors. Clin. Chim. Acta 2006, 368:138-143.
43. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
44. Rea I.M., Candore G., Cavalloni L., Franceschi C., Colonna-Romano G., Lio D., Ross O.A., Caruso C. Longevity. Cytokine gene polymorphisms in multifactorial conditions 2006, 379-394. Florida, US. K. Vandenbroeck (Ed.).
45. Read R.C., Pullin J., Gregory S., Borrow R., Kaczmarski E.B., di Giovine F.S., Dower S.K., Cannings C., Wilson A.G. A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease. J. Infect. Dis. 2001, 184:640-642.
46. Reyes-Gibby C.C., Wu X., Spitz M., Kurzrock R., Fisch M., Bruera E., Shete S. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Oncology 2008, 9:777-785.
47. Rogers J. The inflammatory response in Alzheimer's disease. J. Periodontol. 2008, 79:1535-1543.
48. Sheu B.C., Chang W.C., Cheng C.Y., Lin H.H., Chang D.Y., Huang S.C. Cytokine regulation networks in the cancer microenvironment. Front. Biosci. 2008, 13:6255-6268.
49. Schippers E.F., van't Veer C., van Voorden S., Martina C.A., Huizinga T.W., le Cessie S., van Dissel J.T. IL-10 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 2005, 29:215-228.
50. Schröder N.W., Schumann R.R. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 2005, 5:156-164.
51. Srivastava B., Błazejewska P., Hessmann M., Bruder D., Geffers R., Mauel S., Gruber A.D., Schughart K. Host genetic background strongly influences the response to influenza a virus infections. PLoS ONE 2009, 4:e4857.
52. Uematsu S., Akira S. Toll-like receptors (TLRs) and their ligands. Handb. Exp. Pharmacol. 2008, 183:1-20.
53. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listì F., Nuzzo D., Lio D., Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128:83-91.
54. von Aulock S., Schröder N.W., Gueinzius K., Traub S., Hoffmann S., Graf K., Dimmeler S., Hartung T., Schumann R.R., Hermann C. Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J. Infect. Dis. 2003, 188:938-943.
55. Werner M., Topp R., Wimmer K., Richter K., Bischof W., Wjst M., Heinrich J. TLR4 gene variants modify endotoxin effects on asthma. J. Allergy Clin. Immunol. 2003, 112:323-330.
56. Yandell M., Moore B., Salas F., Mungall C., MacBride A., White C., Reese M.G. Genome-wide analysis of human disease alleles reveals that their locations are correlated in paralogous proteins. PLoS Comput. Biol. 2008, 4:e1000218.
57. Yang I.A., Barton S.J., Rorke S., Cakebread J.A., Keith T.P., Clough J.B., Holgate S.T., Holloway J.W. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun. 2004, 5:41-45.